Technion’s Top Cancer Research

Share on:

TECHNION RESEARCH FOR A CANCER FREE WORLD

September 24th marks World Cancer  Research Day – an international awareness day to raise worldwide attention and inspire action for a cancer-free future. 

The Technion’s Integrated Cancer Center is comprised of: state-of-the-art cancer research in the Rappaport Faculty of Medicine, exceptional engineering and basic science faculties, and five affiliated medical centers – including the Rambam Health Care Campus, which is adjacent to the Rappaport Faculty of Medicine and has the largest cancer facility in northern Israel and one of the largest in the country.

Technion researchers are committed to finding new diagnostic technologies, treatments and cures to create a healthier, cancer-free future.

CURE FOR MELANOMA

Patients often fail to respond to treatments for Melanoma, the deadliest form of skin cancer. However, a team led by Technion Prof. Amir Orian and Technion lecturer Dr. Emily Avitan-Hersh found two proteins that could lead to a new approach to overcoming anti-cancer drug resistance in melanoma.

READ MORE

TREATMENT-RESISTANT CANCER GETS FUNDING BOOST

Why does cancer therapy help some patients and not others? That is a question Technion Prof. Yuval Shaked has been trying to answer with his latest medical research backed by EU funds.

READ MORE

EARLY CARDIOVASCULAR DIAGNOSIS IS THE ANSWER

According to a team of researchers headed by Technion Professor Ami Aronheim, Professor Yuval Shaked, and Dr. Shimrit Avraham, early diagnosis of heart problems in cancer patients could significantly impact treatment success.

READ MORE

BACTERIA TO FIGHT CANCER

Prof. Naama Geva-Zatorsky’s research determines that immune effects of gut bacteria can prevent cancer. Prof. Geva Zatorsky is a member of the Technion’s Rappaport Faculty of Medicine and the Technion Integrated Cancer Center.

READ MORE

 

CANNABIS:  FOR CANCER AND BEYOND

Technion Prof. Dedi Meiri is best known for his cutting-edge research into cannabis as a cancer treatment. He also investigates cannabis’ potential to treat Alzheimer’s, dementia and other neurological diseases.

READ MORE

 

COLD ATMOSPHERIC PLASMA TECHNOLOGY: THE FUTURE OF CANCER TREATMENT

Technion and Rambam Health Care Campus is progressing their research to create a Cold Atmospheric Plasma (CAP) device that can selectively fight cancer cells without damaging surrounding healthy tissue.

READ MORE

A FASTER WAY TO DIAGNOSE & PREDICT CANCER

Technion Prof. Daphne Weihs has found a way to diagnose aggressive cancer tumors in two hours. The next stage of her research is that “[they] may be able to find out more and predict where in the body a secondary tumor is likely to develop.”

READ MORE

CURING CANCER – AND SHRIMP VIRUSES

Technion Researcher Avi Schroeder is leading multiple breakthroughs to fight cancer and cure viruses. “I feel, and this is supported by research data, that in the upcoming decade, we will solve most problems with cancer treatment,” he said. “By 2030, we will reach a place where most cancer patients will be cured.” Today, he is also applying his research to find a vaccine for COVID-19.

READ MORE

PROMISING TUMOR-BUSTING TECHNOLOGY GETS FUNDED

After 10 years of funded research, aMoon, a health-tech fund,makes a $5 million investment in Technion Dean Marcelle Machluf’s venture to help bring her Nano-Ghost tumor-busting technology to market.

READ MORE

 

BLOOD TESTS IN YOUR OWN HOME

Ten years of research went into the creation of PixCell’s HemoScreen hematology analyzer. This enables cancer patients to have their blood tested at home. The patent pending, FDA-approved device is based on technology known as viscoelastic focusing, which was first discovered at the Technion.

READ MORE

 

 

With your help, Technion researchers will help create a future without cancer.  Let’s give them the tools to create a healthier tomorrow for all of us!

SUPPORT TECHNION

Overcoming Drug Resistant Melanoma

Share on:

Researchers at the Technion-Israel Institute of Technology have suggested a new approach to overcoming anticancer-drug resistance in melanoma based on the discovery of  two proteins that together play together a major role in the phenomenon.

The research, published in the Journal of Investigative Dermatology, was headed by Prof. Amir Orian (head of the lab for the study of genetic networks at the Faculty of Medicine and a member of the Technion’s Integrated Cancer Research Center of the Technion’s Rapaport Faculty of Medicine) and Dr. Emily Avitan-Hersh (a lecturer in the Technion’s Faculty of Medicine and deputy director of the dermatology department and a member of the Rambam Clinical Research Institute at Rambam Medical Center), in collaboration with Prof. Ze’ev A. Ronai of the Sanford Burnham Prebys Medical Discovery Institute in California.

READ MORE

New Device Targets Solid Tumors

Share on:

A new technology developed by CAPS Medical, an Or Yehuda based start-up, has innovated Cold Atmospheric Plasma (CAP) technology, usually used to treat superficial solid tumors, to now target solid, internal organ tumors.  In collaboration with the Technion-Israel Institute of Technology and the Rambam Health Care Campus in Haifa, CAPS Medical has created device small enough to administer the treatment on solid tumors inside the body.

CEO, Ilan Uchitel, said “[We are] progressing with our research and development to develop the next generation of our device. We should be ready for commercialization of the treatment by the end of 2022.”

READ MORE